Open access peer-reviewed chapter

Entering a New Era – Prostate Cancer Immuno-Therapy After the FDA Approval for Sipuleucel-T

By Thomas H. Brill

Submitted: January 27th 2011Reviewed: July 4th 2011Published: November 25th 2011

DOI: 10.5772/25553

Downloaded: 1415

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Thomas H. Brill (November 25th 2011). Entering a New Era – Prostate Cancer Immuno-Therapy After the FDA Approval for Sipuleucel-T, Prostate Cancer - Diagnostic and Therapeutic Advances, Philippe E. Spiess, IntechOpen, DOI: 10.5772/25553. Available from:

chapter statistics

1415total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Skeletal Related Events in Prostate Cancer: Important Therapeutic Considerations

By Miguel Álvarez Múgica, Jesús Ma Fernández Gómez, Antonio Jalón Monzón, Verónica Bulnes Vázquez, Erasmo Miguelez and Francisco Valle González

Related Book

First chapter

Epidemiology of Prostate Cancer: The Case of Ethnic German Migrants from the Former Soviet Union

By Volker Winkler and Heiko Becher

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us